Davis Wright Tremaine LLP
Anti-activin A antibodies and uses thereof
The disclosure provides compositions and methods relating to or derived from anti-activin A binding proteins, including antibodies. In particular embodiments, the disclosure provides fully human, humanized, and chimeric anti-activin A antibodies that bind human activin A, activin A-binding fragments and derivatives of such antibodies, and activin A-binding polypeptides comprising such fragments. Other embodiments provide nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having activin A-related disorders or conditions including cachexia related to gonadal cancer, other cancers, rheumatoid arthritis, and other diseases.
Amgen Inc.
C C A C C C C A A C A A A A A A C A A A A
C07K C07K A61P C07K C07K C07K C07K A61P A61P C07K A61P A61P A61P A61P A61P A61P C07K A61P A61K A61P A61P
additional additional inventional additional additional inventional additional inventional inventional additional inventional inventional inventional inventional inventional inventional additional inventional additional inventional inventional
Xiaolan Keith Soo-Nyung Qing Hui-Quan
Zhou Kwak Chen Han